China vaccine maker refutes fraud allegations after CFO quits

A mysterious letter alleging fraudulent activity at China NT Pharma knocked the vaccine company's stock price off its perch. A sharp refutation from the firm's management has, however, calmed investors for now.

By I-Ching Ng

Jun 13, 2012

linkedin facebook twitter

A Hong Kong-listed mainland vaccine maker and drug distributor, China NT Pharma Group Company, saw its stocks rebound after it refuted accusations of false profits that came to light following the departure of its CFO.

Sign-in to access CorporateTreasurer content.

Please sign in to your subscription to unlock full access to our premium CT resources.

Free Registration & 7-Day Trial

Note: This free trial is a one-time offer. You are eligible for one free trial per year.

If you are a treasurer, CFO or senior finance professional at a corporate, please register to the website here.

Questions?

If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Risk & Compliance Moves Strategy Treasury Themes